StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
37
This year
5
Publishing Date
2024 - 02 - 29
1
2024 - 02 - 23
1
2024 - 02 - 14
1
2024 - 01 - 31
1
2024 - 01 - 17
1
2023 - 12 - 15
1
2023 - 12 - 12
1
2023 - 08 - 30
1
2023 - 08 - 25
2
2023 - 08 - 15
1
2023 - 08 - 09
1
2023 - 06 - 27
1
2023 - 06 - 16
1
2023 - 06 - 02
1
2023 - 05 - 12
1
2023 - 04 - 14
1
2023 - 04 - 07
1
2023 - 04 - 04
1
2023 - 01 - 12
1
2022 - 10 - 06
1
2022 - 09 - 21
1
2022 - 09 - 20
1
2022 - 05 - 24
1
2022 - 05 - 10
1
2022 - 03 - 17
1
2022 - 03 - 04
1
2022 - 03 - 01
1
2021 - 11 - 04
1
2021 - 09 - 14
2
2021 - 08 - 19
1
2021 - 07 - 14
1
2021 - 06 - 23
2
2021 - 04 - 29
1
2021 - 03 - 11
1
Sector
Consumer non-durables
1
Health technology
35
Industrial services
1
Manufacturing
7
N/a
1
Non-energy minerals
2
Process industries
3
Producer manufacturing
3
Professional, scientific, and technical services
1
Tags
Advanced
1
Aesthetic
1
Application
3
Approval
2
Approved
1
Ath434
1
Biotech
1
Bladder
1
Cancer
5
Candidate
1
Car-t
1
Cel
1
Cell carcinoma
1
Conference
2
Covid
1
Cystic fibrosis
1
Depression
1
Designation
2
Diabetes
1
Disease
2
Drug
4
Energy
1
Expansion
1
Expected
1
Fast track
1
Fast track designation
1
Favorable
1
Fda
4
Fda-approvals
1
Fibrosis
2
Global
13
Grant
1
Granted
2
Growing
2
Growth
6
Hepzato
1
Immunotherapy
1
Infection
1
Iot
1
Japan
1
Keytruda
1
Lung cancer
3
Macular
1
Market
18
Melanoma
1
N/a
36
Nash
1
Natural
1
New drug
1
Obesity
1
Phase 3
2
Positive
3
Reach
2
Report
9
Results
3
Risk
2
Therapeutics
2
Therapy
3
Treatment
36
Trial
2
Entities
3m company
1
Abbott laboratories
4
Abbvie inc.
5
Agilent technologies, inc.
1
Align technology, inc.
1
Alterity therapeutics limited
1
Amgen inc.
1
Angiodynamics, inc.
1
Apollo endosurgery, inc.
1
Astellas pharma inc
2
Astrazeneca plc
2
Atlas copco ab
1
Bausch health companies inc.
1
Bio-rad laboratories, inc.
1
Boston scientific corporation
1
Bristol-myers squibb company
2
Clinuvel pharmaceuticals ltd
1
Codexis, inc.
1
Coherus biosciences, inc.
3
Danaher corporation
1
Delcath systems, inc.
1
Ecolab inc.
1
Elanco animal health incorporated
1
Eli lilly and company
6
Eloxx pharmaceuticals, inc.
1
Gilead sciences, inc.
1
Glaxosmithkline plc
4
Hologic, inc.
1
Incyte corporation
1
Ingersoll rand inc.
1
Johnson & johnson
9
Karyopharm therapeutics inc.
1
Koninklijke philips n.v.
1
Lipocine inc.
1
Medies
1
Medtronic plc
2
Novartis ag
4
Novo nordisk a/s
1
Oramed pharmaceuticals inc.
1
Penumbra, inc.
1
Perrigo company
1
Pfizer, inc.
5
Posco
1
Prestige consumer healthcare inc.
1
Qiagen n.v.
1
Reckitt benckiser group plc
1
Regeneron pharmaceuticals, inc.
1
Sanofi
5
Stryker corporation
1
Surmodics, inc.
1
Takeda pharmaceutical company limited
1
Technipfmc plc
1
Teleflex incorporated
1
Terumo corp
1
Teva pharmaceutical industries ltd
3
Thermo fisher scientific inc
2
Tonix pharmaceuticals holding corp.
1
Ucb s.a.
1
Viatris inc.
3
Xylem inc.
2
Symbols
A
1
ABBV
5
ABT
4
ALGN
1
ALPMF
2
ALPMY
2
AMGN
1
ANGO
1
APEN
1
ATHE
1
ATLCY
1
ATLKY
1
AZN
2
AZNCF
2
BHC
1
BIO
1
BMY
2
BSX
1
CDXS
1
CHRS
3
CLVLF
1
CLVLY
1
DCTH
1
DHR
1
ECL
1
ELAN
1
ELOX
1
FTI
1
GILD
1
GLAXF
3
GSK
4
HOLX
1
INCY
1
IR
1
JNJ
9
KPTI
1
LLY
6
LPCN
1
MDT
2
MEDE
1
MMM
1
NVO
1
NVS
4
NVSEF
4
ORMP
1
PBH
1
PEN
1
PFE
5
PHG
1
PKX
1
PRGO
1
QGEN
1
RBGLY
1
RBGPF
1
SNY
5
SNYNF
4
TEVJF
3
TMO
2
VTRS
3
XYL
2
Exchanges
Nasdaq
32
Nyse
27
Crawled Date
2024 - 02 - 29
1
2024 - 02 - 23
1
2024 - 02 - 14
1
2024 - 01 - 31
1
2024 - 01 - 17
1
2023 - 12 - 15
1
2023 - 12 - 12
1
2023 - 08 - 30
1
2023 - 08 - 25
2
2023 - 08 - 15
1
2023 - 08 - 09
1
2023 - 06 - 27
1
2023 - 06 - 16
1
2023 - 06 - 02
1
2023 - 05 - 12
1
2023 - 04 - 14
1
2023 - 04 - 07
1
2023 - 04 - 04
1
2023 - 01 - 12
1
2022 - 10 - 06
1
2022 - 09 - 21
1
2022 - 09 - 20
1
2022 - 05 - 24
1
2022 - 05 - 10
1
2022 - 03 - 17
1
2022 - 03 - 04
1
2022 - 03 - 01
1
2021 - 11 - 05
1
2021 - 09 - 14
2
2021 - 08 - 19
1
2021 - 07 - 14
1
2021 - 06 - 23
2
2021 - 04 - 30
1
2021 - 03 - 11
1
Crawled Time
00:00
129
00:01
3
00:20
24
01:00
97
02:00
37
03:00
26
04:00
19
04:20
16
05:00
29
06:00
66
07:00
66
08:00
67
08:20
6
09:00
77
09:08
3
10:00
64
10:16
6
11:00
309
11:01
3
11:03
3
12:00
757
12:01
12
12:03
16
12:07
4
12:11
3
12:15
67
12:20
136
12:30
119
13:00
628
13:01
3
13:02
4
13:03
14
13:05
4
13:15
41
13:20
153
13:30
110
14:00
444
14:01
12
14:02
4
14:03
6
14:15
22
14:20
60
14:30
73
15:00
232
15:01
7
15:15
9
15:20
37
15:30
56
16:00
156
16:20
32
17:00
158
18:00
131
19:00
136
20:00
149
20:20
17
21:00
188
22:00
185
22:01
5
22:15
7
23:00
166
Source
alteritytherapeutics.com
1
www.biospace.com
1
www.globenewswire.com
6
www.prnewswire.com
29
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
treatment
crawled time :
02:00
save search
Global Metal Heat Treatment Market Projects Significant Growth, Accelerating at 3.11% CAGR through 2028
Published:
2024-02-29
(Crawled : 02:00)
- prnewswire.com
VLPNY
|
$5.19
1.7K
|
Manufacturing
|
-4.77%
|
O:
0.0%
H:
0.0%
C:
0.0%
treatment
global
market
Binge-eating Disorder Treatment Market Research Report 2024
Published:
2024-02-23
(Crawled : 02:00)
- prnewswire.com
VTRS
|
$11.22
1.08%
510K
|
Health Technology
|
-16.92%
|
O:
0.0%
H:
1.93%
C:
1.27%
TNXP
|
$0.1594
790K
|
Health Technology
|
-49.43%
|
O:
0.0%
H:
4.3%
C:
1.77%
report
treatment
research
market
Lice Treatment Global Market Report 2024: Global Lice Treatment Market Witnesses Substantial Growth as Consumer Preferences Shift Toward Natural Solutions
Published:
2024-02-14
(Crawled : 02:00)
- prnewswire.com
RBGPF
|
$52.0
34K
|
Consumer Non-Durables
|
-28.91%
|
O:
-0.94%
H:
0.01%
C:
0.01%
SNYNF
|
News
|
$92.7
1.4K
|
Health Technology
|
-0.29%
|
O:
-2.71%
H:
0.0%
C:
0.0%
RBGLY
|
$10.29
1.4M
|
Manufacturing
|
-28.74%
|
O:
-0.69%
H:
0.35%
C:
0.35%
PBH
|
$68.52
0.72%
22K
|
Health Technology
|
2.21%
|
O:
0.06%
H:
2.84%
C:
1.65%
PRGO
|
$29.95
-0.3%
180K
|
Health Technology
|
-5.42%
|
O:
0.41%
H:
0.44%
C:
-1.03%
JNJ
|
News
|
$144.86
0.06%
2.8M
|
Health Technology
|
-8.2%
|
O:
-0.91%
H:
0.0%
C:
0.0%
ELAN
|
$13.55
1.04%
1.1M
|
Process Industries
|
-13.07%
|
O:
1.53%
H:
1.16%
C:
0.82%
SNY
|
News
|
$45.445
-1.44%
2.6M
|
Health Technology
|
-0.13%
|
O:
-1.1%
H:
0.0%
C:
0.0%
report
natural
treatment
global
solutions
growth
market
Astellas Submits Supplemental New Drug Application in Japan for PADCEV™ (enfortumab vedotin (genetical recombination)) with KEYTRUDA® (pembrolizumab (genetical recombination)) for First-Line Treatment of Advanced Bladder Cancer
Published:
2024-01-31
(Crawled : 02:00)
- prnewswire.com
ALPMF
|
News
|
$9.594
2.2K
|
Health Technology
|
-16.94%
|
O:
4.34%
H:
0.0%
C:
0.0%
ALPMY
|
News
|
$9.46
500K
|
Manufacturing
|
-19.27%
|
O:
0.0%
H:
1.38%
C:
0.26%
PFE
A
|
$25.325
-0.37%
15M
|
Health Technology
|
-5.92%
|
O:
0.56%
H:
1.25%
C:
-0.33%
keytruda
drug
japan
bladder
cancer
treatment
application
advanced
Global Pseudomonas Aeruginosa Infection Treatment Market Report 2024-2034: Rising Antibiotic Resistance Drives Demand for Pseudomonas Aeruginosa Infection Treatments
Published:
2024-01-17
(Crawled : 02:00)
- prnewswire.com
GLAXF
|
$20.2
510
|
Health Technology
|
3.11%
|
O:
-0.56%
H:
0.0%
C:
0.0%
SNYNF
|
News
|
$92.7
1.4K
|
Health Technology
|
-10.78%
|
O:
-1.83%
H:
0.0%
C:
0.0%
NVS
|
News
|
$92.61
-0.51%
430K
|
Health Technology
|
-13.57%
|
O:
0.49%
H:
0.18%
C:
0.04%
JNJ
|
News
|
$144.86
0.06%
2.8M
|
Health Technology
|
-10.59%
|
O:
-1.02%
H:
0.0%
C:
0.0%
GSK
|
$39.44
-0.4%
560K
|
Health Technology
|
-0.7%
|
O:
-0.08%
H:
0.1%
C:
-0.18%
ABT
|
News
|
$105.52
-0.36%
1.6M
|
Health Technology
|
-4.89%
|
O:
0.12%
H:
0.77%
C:
0.27%
SNY
|
News
|
$45.445
-1.44%
2.6M
|
Health Technology
|
-10.76%
|
O:
0.45%
H:
0.06%
C:
-0.5%
GILD
|
$65.99
-1.4%
1.9M
|
Health Technology
|
-22.17%
|
O:
-0.19%
H:
0.87%
C:
0.76%
report
infection
treatment
global
market
Global Branded PAH Therapeutics Market Report 2023-2029 - Targeted Therapies Revolutionize Treatment, Growing Prevalence Spurs Market Expansion for Branded Therapeutics
Published:
2023-12-15
(Crawled : 02:00)
- prnewswire.com
JNJ
|
News
|
$144.86
0.06%
2.8M
|
Health Technology
|
-7.51%
|
O:
-0.39%
H:
0.0%
C:
0.0%
LLY
|
News
|
$749.245
-0.2%
550K
|
Health Technology
|
26.46%
|
O:
-4.44%
H:
0.0%
C:
0.0%
report
expansion
global
growing
therapeutics
market
New Analyses Demonstrate Versatility and Continued Efficacy of TALVEY™ in the Treatment of Patients with Relapsed or Refractory Multiple Myeloma
Published:
2023-12-12
(Crawled : 02:00)
- prnewswire.com
JNJ
|
News
|
$144.86
0.06%
2.8M
|
Health Technology
|
-6.42%
|
O:
0.1%
H:
0.0%
C:
0.0%
treatment
Ligases as Key Players in Disease Treatment Propel Global Market Growth in the Forecast Period 2023-2027
Published:
2023-08-30
(Crawled : 02:00)
- prnewswire.com
QGEN
|
$39.49
0.66%
350K
|
Health Technology
|
-14.17%
|
O:
0.83%
H:
0.46%
C:
0.04%
BIO
|
$279.61
-3.87%
150K
|
Health Technology
|
-26.0%
|
O:
0.13%
H:
0.87%
C:
0.19%
A
|
$134.06
-0.36%
710K
|
Health Technology
|
14.25%
|
O:
2.17%
H:
0.49%
C:
0.28%
QGEN
|
$39.49
0.66%
350K
|
Health Technology
|
-14.17%
|
O:
0.83%
H:
0.46%
C:
0.04%
CDXS
|
$2.85
3.26%
180K
|
Process Industries
|
52.51%
|
O:
1.12%
H:
0.55%
C:
-2.76%
propel
disease
treatment
global
growth
market
Global Obesity Treatment Market Poised to Reach $26.44 Billion by 2028, Fueled by Rising Prevalence and Innovative Interventions
Published:
2023-08-25
(Crawled : 02:00)
- prnewswire.com
PFE
A
|
$25.325
-0.37%
15M
|
Health Technology
|
-29.7%
|
O:
-0.06%
H:
1.52%
C:
0.66%
NVO
|
News
|
$123.37
-0.93%
1.4M
|
Health Technology
|
34.37%
|
O:
-0.34%
H:
1.29%
C:
0.93%
MDT
|
News
|
$78.7
-0.48%
1.7M
|
Health Technology
|
-3.95%
|
O:
-0.98%
H:
1.19%
C:
0.82%
JNJ
|
News
|
$144.86
0.06%
2.8M
|
Health Technology
|
-11.73%
|
O:
0.51%
H:
0.0%
C:
0.0%
ABBV
|
$167.2
1.8%
1.3M
|
Health Technology
|
11.38%
|
O:
-0.11%
H:
0.44%
C:
-0.22%
obesity
reach
treatment
global
market
Global Autoimmune Treatment Market Soars to $288.32 Billion by 2028, Driven by a 7.72% CAGR from 2023
Published:
2023-08-25
(Crawled : 02:00)
- prnewswire.com
AZNCF
|
$140.15
560
|
Health Technology
|
-0.51%
|
O:
-3.27%
H:
3.65%
C:
3.36%
ALPMY
|
News
|
$9.46
500K
|
Manufacturing
|
-37.61%
|
O:
-4.14%
H:
5.37%
C:
4.39%
NVS
|
News
|
$92.61
-0.51%
430K
|
Health Technology
|
-7.7%
|
O:
0.67%
H:
0.37%
C:
0.26%
JNJ
|
News
|
$144.86
0.06%
2.8M
|
Health Technology
|
-11.73%
|
O:
0.51%
H:
0.0%
C:
0.0%
ABBV
|
$167.2
1.8%
1.3M
|
Health Technology
|
11.38%
|
O:
-0.11%
H:
0.44%
C:
-0.22%
ABT
|
News
|
$105.52
-0.36%
1.6M
|
Health Technology
|
2.78%
|
O:
-0.73%
H:
0.0%
C:
0.0%
AZN
|
$68.635
0.15%
1.3M
|
Health Technology
|
0.55%
|
O:
0.22%
H:
0.6%
C:
0.31%
AMGN
|
$265.48
0.53%
360K
|
Health Technology
|
4.02%
|
O:
0.19%
H:
0.25%
C:
-0.28%
treatment
global
market
Delcath Systems, Inc. Announces FDA Approval of HEPZATO KIT™ for the Treatment of Adult Patients with Unresectable Hepatic-Dominant Metastatic Uveal Melanoma
Published:
2023-08-15
(Crawled : 02:00)
- prnewswire.com
DCTH
|
$4.93
10.17%
160K
|
Health Technology
|
51.6%
|
O:
87.18%
H:
24.49%
C:
-2.91%
fda
melanoma
approval
treatment
hepzato
Global Clear Aligners Market Analysis Report 2023: Addressing Malocclusions - Clear Aligners Emerge as a Preferred Treatment Choice
Published:
2023-08-09
(Crawled : 02:00)
- prnewswire.com
DHR
|
$237.72
-0.7%
1.4M
|
Health Technology
|
-5.8%
|
O:
1.62%
H:
0.2%
C:
-1.25%
MMM
|
$91.63
0.74%
950K
|
Producer Manufacturing
|
-12.65%
|
O:
-0.22%
H:
0.76%
C:
-0.18%
ALGN
|
$307.56
2.47%
110K
|
Health Technology
|
-14.21%
|
O:
0.87%
H:
0.0%
C:
0.0%
report
treatment
global
market
Global CIN & HR-HPV Treatment Market Report 2023: A $17.16 Billion Market by 2027 - Opportunities in the Development and Launch of Innovative Products
Published:
2023-06-27
(Crawled : 02:00)
- prnewswire.com
TMO
|
News
|
$542.43
-0.88%
810K
|
Health Technology
|
4.83%
|
O:
-0.32%
H:
0.38%
C:
-2.06%
PKX
|
$70.465
3.78%
39K
|
Non-Energy Minerals
|
-11.29%
|
O:
1.24%
H:
0.4%
C:
0.27%
ABT
|
News
|
$105.52
-0.36%
1.6M
|
Health Technology
|
-0.53%
|
O:
0.35%
H:
0.05%
C:
-1.01%
HOLX
|
$74.97
0.07%
340K
|
Health Technology
|
-7.59%
|
O:
-0.11%
H:
0.31%
C:
-0.2%
report
treatment
global
market
Global Axial Spondyloarthritis Treatment Market to 2027: Increase in the Number of Approved Biosimilars Fuels the Sector
Published:
2023-06-16
(Crawled : 02:00)
- prnewswire.com
UCBJY
|
$64.07
72K
|
Manufacturing
|
37.7%
|
O:
1.21%
H:
0.0%
C:
-0.2%
PFE
A
|
$25.325
-0.37%
15M
|
Health Technology
|
-36.05%
|
O:
0.28%
H:
1.25%
C:
0.5%
JNJ
|
News
|
$144.86
0.06%
2.8M
|
Health Technology
|
-11.58%
|
O:
0.46%
H:
0.31%
C:
-0.15%
LLY
|
News
|
$749.245
-0.2%
550K
|
Health Technology
|
65.39%
|
O:
0.41%
H:
0.26%
C:
-1.77%
BMY
|
$48.145
0.64%
2.5M
|
Health Technology
|
-25.37%
|
O:
0.32%
H:
2.1%
C:
1.97%
approved
treatment
global
market
Vanda Pharmaceuticals Announces Orphan Drug Designation Granted for VCA-894A, a Novel Antisense Oligonucleotide Candidate for the Treatment of Charcot-Marie-Tooth Disease, Type 2S
Published:
2023-06-02
(Crawled : 02:00)
- prnewswire.com
VNDA
|
News
|
$4.98
-4.96%
1.5M
|
Health Technology
|
-11.19%
|
O:
0.85%
H:
2.18%
C:
1.85%
vca-894
drug
candidate
granted
treatment
pharmaceuticals
designation
Global Cystic Fibrosis Treatment Market Report 2023: Sector is Expected to Reach $25.7 Billion by 2031 at a CAGR of 13.4%
Published:
2023-05-12
(Crawled : 02:00)
- prnewswire.com
JNJ
|
News
|
$144.86
0.06%
2.8M
|
Health Technology
|
-10.08%
|
O:
0.23%
H:
0.12%
C:
-0.36%
VRTX
|
$393.86
0.19%
160K
|
Health Technology
|
12.19%
|
O:
0.01%
H:
0.45%
C:
-0.86%
report
expected
reach
treatment
fibrosis
global
market
Stomach Cancer Treatment Market Report 2023: Growing Demand for Painless Low-Cost Treatment and Favorable Reimbursement Scenarios Bolsters Sector
Published:
2023-04-14
(Crawled : 02:00)
- prnewswire.com
PFE
A
|
$25.325
-0.37%
15M
|
Health Technology
|
-38.7%
|
O:
0.08%
H:
0.49%
C:
-0.76%
LLY
|
News
|
$749.245
-0.2%
550K
|
Health Technology
|
100.13%
|
O:
-0.24%
H:
0.55%
C:
0.13%
report
favorable
cancer
treatment
growing
market
Deep Venous Disease Treatment Devices Global Market Report 2023: Increasing Awareness of Preventative Devices Leading to Growth
Published:
2023-04-07
(Crawled : 02:00)
- prnewswire.com
PEN
F
|
$205.15
-1.69%
71K
|
Health Technology
|
Email alert
Add to watchlist
ABT
|
News
|
$105.52
-0.36%
1.6M
|
Health Technology
|
Email alert
Add to watchlist
BSX
|
$67.96
1.3M
|
Health Technology
|
Email alert
Add to watchlist
SYK
|
$331.43
-1.37%
430K
|
Health Technology
|
Email alert
Add to watchlist
ANGO
|
$6.325
-0.08%
59K
|
Health Technology
|
Email alert
Add to watchlist
SRDX
|
$26.81
1.09%
4.7K
|
Health Technology
|
Email alert
Add to watchlist
TRUMY
|
$16.69
54K
|
Manufacturing
|
Email alert
Add to watchlist
PHG
|
News
|
$20.075
-0.37%
220K
|
Health Technology
|
Email alert
Add to watchlist
TFX
|
$208.45
0.07%
21K
|
Health Technology
|
Email alert
Add to watchlist
TRUMF
|
$17.112
1.5K
|
Health Technology
|
Email alert
Add to watchlist
MDT
|
News
|
$78.7
-0.48%
1.7M
|
Health Technology
|
Email alert
Add to watchlist
disease
report
treatment
global
growth
market
Global Depression Treatment Market to 2030: Rising Prevalence of Psychiatric Diseases and Development of Innovative Medications for Treatment-resistant Depression Drives Growth
Published:
2023-04-04
(Crawled : 02:00)
- prnewswire.com
TAK
|
$13.215
0.49%
210K
|
Health Technology
|
-20.4%
|
O:
-0.12%
H:
1.55%
C:
1.03%
LLY
|
News
|
$749.245
-0.2%
550K
|
Health Technology
|
114.05%
|
O:
0.38%
H:
1.97%
C:
0.72%
BMY
|
$48.145
0.64%
2.5M
|
Health Technology
|
-30.75%
|
O:
0.13%
H:
0.0%
C:
-1.25%
SNY
|
News
|
$45.445
-1.44%
2.6M
|
Health Technology
|
-15.25%
|
O:
-0.1%
H:
0.0%
C:
0.0%
depression
treatment
global
growth
market
Oramed Announces Top-line Results from Phase 3 Trial of ORMD-0801 for the Treatment of Type 2 Diabetes
Published:
2023-01-12
(Crawled : 02:00)
- prnewswire.com
ORMP
|
$2.24
-3.86%
86K
|
Health Technology
|
-78.41%
|
O:
-78.04%
H:
19.41%
C:
7.17%
ormd-0801
treatment
trial
diabetes
← Previous
1
2
Next →
Gainers vs Losers
82%
18%
Top 10 Gainers
AGBA
|
$0.7995
99.88%
73M
|
Finance
BPTH
|
$6.21
91.67%
58M
|
Health Technology
INVO
|
$1.36
78.95%
3.6M
|
Health Technology
TIRX
|
$0.8258
70.34%
50M
|
ISPC
|
$0.307
44.13%
3.6M
|
Professional, Scientific, and T...
SINT
|
$0.0519
39.14%
350M
|
Health Technology
VTNR
S
|
$1.295
32.25%
5.5M
|
Industrial Services
ALRN
|
$5.53
30.12%
250K
|
Health Technology
HOLO
|
$2.86
27.68%
28M
|
XPON
|
$2.43
25.91%
7.2M
|
Your saved searches
Save your searches and get alerts when important news are released.